Zoetis Stock Hits Day High with Strong 3.68% Intraday Performance

Zoetis, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable uptick in its stock performance today, gaining 3.68% as of September 30, 2025. The stock reached an intraday high of USD 146.84, reflecting a strong market response.
In terms of performance metrics, Zoetis has shown resilience with a high return on capital employed (ROCE) of 33.61%, indicating effective management efficiency. The company also boasts a low debt to EBITDA ratio of 1.22 times, underscoring its strong ability to service debt. Over the past year, while the stock has faced a decline of 24.91%, its profits have increased by 6.1%, showcasing a healthy growth trajectory.

Zoetis has consistently delivered positive results for six consecutive quarters, with operating cash flow reaching a peak of USD 2,929 million. The company’s dividend per share stands at USD 6.42, reflecting its commitment to returning value to shareholders. With a market capitalization of USD 71,581 million, Zoetis continues to maintain a significant presence in the market, supported by high institutional holdings at 98.14%.